Iodine-125 interstitial implants as salvage therapy for recurrent gynecologic malignancies.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2015548.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Twenty-one patients with the diagnosis of recurrent gynecologic pelvic malignancy from various primary sites were treated with iodine-125 (I-125) interstitial implants. Eighteen of these patients had been treated with a combination of surgery and radiation therapy for their primary malignancies and 90% had responded. Seventy-five percent had complete local responses. The overall survival time, volume-response relationship, and complications are discussed and the radioresponse of various histologic types is presented.
Medical subject headings
- Carcinoma
- Genital Neoplasms, Female
- Iodine Radioisotopes
- Neoplasm Recurrence, Local